Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

September 01, 2003; Volume 31,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Bajpai, Manoj

    1. You have access
      ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103
  2. Bedard, Leanne L.

    1. You have access
      BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134
  3. Bend, John R.

    1. You have access
      BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134
  4. Benedek, Irma H.

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  5. Berbaum, Jennifer

    1. You have access
      GENERATION AND VALIDATION OF RAPID COMPUTATIONAL FILTERS FOR CYP2D6 AND CYP3A4
      Sean Ekins, Jennifer Berbaum and Richard K. Harrison
      Drug Metabolism and Disposition September 2003, 31 (9) 1077-1080; DOI: https://doi.org/10.1124/dmd.31.9.1077
  6. Boobis, Alan R.

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  7. Brennan, James M.

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  8. Burchell, Brian

    1. You have access
      CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187

C

  1. Caggana, Michele

    1. You have access
      SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081
  2. Castell, José V.

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  3. Charman, William N.

    1. You have access
      APPLICATION OF COMPARTMENTAL MODELING TO AN EXAMINATION OF IN VITRO INTESTINAL PERMEABILITY DATA: ASSESSING THE IMPACT OF TISSUE UPTAKE, P-GLYCOPROTEIN, AND CYP3A
      Brendan M. Johnson, William N. Charman and Christopher J. H. Porter
      Drug Metabolism and Disposition September 2003, 31 (9) 1151-1160; DOI: https://doi.org/10.1124/dmd.31.9.1151
  4. Chen, Ying

    1. You have access
      SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081
  5. Cherrington, N. J.

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES
      A. L. Slitt, N. J. Cherrington, J. M. Maher and C. D. Klaassen
      Drug Metabolism and Disposition September 2003, 31 (9) 1176-1186; DOI: https://doi.org/10.1124/dmd.31.9.1176
  6. Clarke, Stephen E.

    1. You have access
      MULTISITE KINETIC ANALYSIS OF INTERACTIONS BETWEEN PROTOTYPICAL CYP3A4 SUBGROUP SUBSTRATES: MIDAZOLAM, TESTOSTERONE, AND NIFEDIPINE
      Aleksandra Galetin, Stephen E. Clarke and J. Brian Houston
      Drug Metabolism and Disposition September 2003, 31 (9) 1108-1116; DOI: https://doi.org/10.1124/dmd.31.9.1108
  7. Corcos, Laurent

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  8. Coughtrie, Michael W. H.

    1. You have access
      CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187
  9. Court, Michael H.

    1. You have access
      EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

D

  1. Dai, Renke

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  2. Ding, Xinxin

    1. You have access
      SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081
  3. Duan, Su X.

    1. You have access
      EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

E

  1. Edwards, Robert J.

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  2. Ekins, Sean

    1. You have access
      GENERATION AND VALIDATION OF RAPID COMPUTATIONAL FILTERS FOR CYP2D6 AND CYP3A4
      Sean Ekins, Jennifer Berbaum and Richard K. Harrison
      Drug Metabolism and Disposition September 2003, 31 (9) 1077-1080; DOI: https://doi.org/10.1124/dmd.31.9.1077
  3. Ethell, Brian T.

    1. You have access
      CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187

F

  1. Finel, Moshe

    1. You have access
      GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117
  2. Fiske, William D.

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

G

  1. Galetin, Aleksandra

    1. You have access
      ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086
    2. You have access
      MULTISITE KINETIC ANALYSIS OF INTERACTIONS BETWEEN PROTOTYPICAL CYP3A4 SUBGROUP SUBSTRATES: MIDAZOLAM, TESTOSTERONE, AND NIFEDIPINE
      Aleksandra Galetin, Stephen E. Clarke and J. Brian Houston
      Drug Metabolism and Disposition September 2003, 31 (9) 1108-1116; DOI: https://doi.org/10.1124/dmd.31.9.1108
  2. Gan, Liang-Shang

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  3. Gilbert, Darryl

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  4. Gillespie, T. A.

    1. You have access
      METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142
  5. Goldfarb, Peter S.

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  6. Gómez-Lechón, Maria-José

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  7. Greenblatt, David J.

    1. You have access
      EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125
  8. Guillouzo, Andre

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

H

  1. Hao, Qin

    1. You have access
      EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125
  2. Harrison, Richard K.

    1. You have access
      GENERATION AND VALIDATION OF RAPID COMPUTATIONAL FILTERS FOR CYP2D6 AND CYP3A4
      Sean Ekins, Jennifer Berbaum and Richard K. Harrison
      Drug Metabolism and Disposition September 2003, 31 (9) 1077-1080; DOI: https://doi.org/10.1124/dmd.31.9.1077
  3. Hidestrand, Mats

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  4. Hines, Ronald N.

    1. You have access
      PUBLICATION OF STAND-ALONE SINGLE NUCLEOTIDE POLYMORPHISM (SNP) DISCOVERY DATA
      Ronald N. Hines
      Drug Metabolism and Disposition September 2003, 31 (9) 1073; DOI: https://doi.org/10.1124/dmd.31.9.1073
  5. Ho, Rodney J. Y.

    1. You have access
      ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103
  6. Hood, Alan M.

    1. You have access
      CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187
  7. Houston, J. Brian

    1. You have access
      ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086
    2. You have access
      MULTISITE KINETIC ANALYSIS OF INTERACTIONS BETWEEN PROTOTYPICAL CYP3A4 SUBGROUP SUBSTRATES: MIDAZOLAM, TESTOSTERONE, AND NIFEDIPINE
      Aleksandra Galetin, Stephen E. Clarke and J. Brian Houston
      Drug Metabolism and Disposition September 2003, 31 (9) 1108-1116; DOI: https://doi.org/10.1124/dmd.31.9.1108

I

  1. Ingelman-Sundberg, Magnus

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

J

  1. Johnson, Brendan M.

    1. You have access
      APPLICATION OF COMPARTMENTAL MODELING TO AN EXAMINATION OF IN VITRO INTESTINAL PERMEABILITY DATA: ASSESSING THE IMPACT OF TISSUE UPTAKE, P-GLYCOPROTEIN, AND CYP3A
      Brendan M. Johnson, William N. Charman and Christopher J. H. Porter
      Drug Metabolism and Disposition September 2003, 31 (9) 1151-1160; DOI: https://doi.org/10.1124/dmd.31.9.1151
  2. Jolley, Summer

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

K

  1. Kim, Kyoung-Ah

    1. You have access
      INHIBITORY EFFECT OF GLYBURIDE ON HUMAN CYTOCHROME P450 ISOFORMS IN HUMAN LIVER MICROSOMES
      Kyoung-Ah Kim and Ji-Young Park
      Drug Metabolism and Disposition September 2003, 31 (9) 1090-1092; DOI: https://doi.org/10.1124/dmd.31.9.1090
  2. Kim, Sean

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  3. Klaassen, C. D.

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES
      A. L. Slitt, N. J. Cherrington, J. M. Maher and C. D. Klaassen
      Drug Metabolism and Disposition September 2003, 31 (9) 1176-1186; DOI: https://doi.org/10.1124/dmd.31.9.1176
  4. Knadler, M. P.

    1. You have access
      METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142
  5. Kostiainen, Risto

    1. You have access
      GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117
  6. Krishnaswamy, Soundarajan

    1. You have access
      EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125
  7. Kuan, H-Y.

    1. You have access
      METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142
  8. Kuo, F.

    1. You have access
      METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142
  9. Kurkela, Mika

    1. You have access
      GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117
  10. Kuuranne, Tiia

    1. You have access
      GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117

L

  1. Lake, Brian G.

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  2. Lantz, R. J.

    1. You have access
      METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142
  3. LeCluyse, Edward

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  4. Lee, Frank W.

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  5. Lewis, David F.V.

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  6. Li, Yinghe

    1. You have access
      SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161
  7. Lin, Jianrong

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  8. Lin, Yuh

    1. You have access
      SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161
  9. Liu, Yiqin

    1. You have access
      SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081
  10. Lu, Ping

    1. You have access
      SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161
  11. Luo, Gang

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

M

  1. Mackenzie, Peter I.

    1. You have access
      ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086
  2. Maher, J. M.

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES
      A. L. Slitt, N. J. Cherrington, J. M. Maher and C. D. Klaassen
      Drug Metabolism and Disposition September 2003, 31 (9) 1176-1186; DOI: https://doi.org/10.1124/dmd.31.9.1176
  3. Massey, Thomas E.

    1. You have access
      BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134
  4. McConnachie, Lisa A.

    1. You have access
      ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103
  5. Mei, Qin

    1. You have access
      SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161
  6. Miners, John O.

    1. You have access
      ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086

N

  1. Norcross, Ryan

    1. You have access
      SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161
  2. Nyman, Leena

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

P

  1. Park, Ji-Young

    1. You have access
      INHIBITORY EFFECT OF GLYBURIDE ON HUMAN CYTOCHROME P450 ISOFORMS IN HUMAN LIVER MICROSOMES
      Kyoung-Ah Kim and Ji-Young Park
      Drug Metabolism and Disposition September 2003, 31 (9) 1090-1092; DOI: https://doi.org/10.1124/dmd.31.9.1090
  2. Patten, Christopher J.

    1. You have access
      EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125
  3. Pelkonen, Olavi

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  4. Periandythevar, Parameswaran

    1. You have access
      SPURIOUS OBSERVATION OF SPLENIC CYP2B1 EXPRESSION
      Meena R. Sharma, Parameswaran Periandythevar and Bernard H. Shapiro
      Drug Metabolism and Disposition September 2003, 31 (9) 1074-1076; DOI: https://doi.org/10.1124/dmd.31.9.1074
  5. Petsikas, Dimitri

    1. You have access
      BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134
  6. Phillips, Brian

    1. You have access
      ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103
  7. Pihlavisto, Pia

    1. You have access
      CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187
  8. Porter, Christopher J. H.

    1. You have access
      APPLICATION OF COMPARTMENTAL MODELING TO AN EXAMINATION OF IN VITRO INTESTINAL PERMEABILITY DATA: ASSESSING THE IMPACT OF TISSUE UPTAKE, P-GLYCOPROTEIN, AND CYP3A
      Brendan M. Johnson, William N. Charman and Christopher J. H. Porter
      Drug Metabolism and Disposition September 2003, 31 (9) 1151-1160; DOI: https://doi.org/10.1124/dmd.31.9.1151
  9. Price, Roger J.

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

R

  1. Rash, T. J.

    1. You have access
      METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142
  2. Reid, Ken R.

    1. You have access
      BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134
  3. Ren, Xiang

    1. You have access
      SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081
  4. Renwick, Anthony B.

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  5. Rodrigues, A. David

    1. You have access
      SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161
  6. Rushmore, Thomas H.

    1. You have access
      SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

S

  1. Salonen, Jarmo S.

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  2. Sandig, Grit

    1. You have access
      SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161
  3. Schänzer, Wilhelm

    1. You have access
      GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117
  4. Shapiro, Bernard H.

    1. You have access
      SPURIOUS OBSERVATION OF SPLENIC CYP2B1 EXPRESSION
      Meena R. Sharma, Parameswaran Periandythevar and Bernard H. Shapiro
      Drug Metabolism and Disposition September 2003, 31 (9) 1074-1076; DOI: https://doi.org/10.1124/dmd.31.9.1074
  5. Sharma, Meena R.

    1. You have access
      SPURIOUS OBSERVATION OF SPLENIC CYP2B1 EXPRESSION
      Meena R. Sharma, Parameswaran Periandythevar and Bernard H. Shapiro
      Drug Metabolism and Disposition September 2003, 31 (9) 1074-1076; DOI: https://doi.org/10.1124/dmd.31.9.1074
  6. Shen, Danny D.

    1. You have access
      ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103
  7. Shou, Magang

    1. You have access
      SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161
  8. Sinz, Michael

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  9. Skinner, M.

    1. You have access
      METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142
  10. Slitt, A. L.

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES
      A. L. Slitt, N. J. Cherrington, J. M. Maher and C. D. Klaassen
      Drug Metabolism and Disposition September 2003, 31 (9) 1176-1186; DOI: https://doi.org/10.1124/dmd.31.9.1176
  11. Smith, Graeme B. J.

    1. You have access
      BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134
  12. Solon, Eric

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  13. Stone, Andrew N.

    1. You have access
      ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086

T

  1. Taavitsainen, Päivi

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093
  2. Taskinen, Jyrki

    1. You have access
      CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187
  3. Thevis, Mario

    1. You have access
      GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117

V

  1. von Moltke, Lisa L.

    1. You have access
      EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

W

  1. Wang, Lifei

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170
  2. Watts, Patricia

    1. You have access
      COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

Y

  1. Yang, Tian J.

    1. You have access
      CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

Z

  1. Zhang, Qing-Yu

    1. You have access
      SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081
  2. Zhang, Xiuling

    1. You have access
      SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 31 (9)
Drug Metabolism and Disposition
Vol. 31, Issue 9
1 Sep 2003
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics